Nitinol has arrived in minimally invasive glaucoma surgery, making symptom management for the progressive eye disease safer ...

Single-cell transcriptomics identifies three discrete mouse trabecular meshwork subtypes and demonstrates that an Lmx1b glaucoma mutation drives mitochondrial dysfunction and elevated intraocular ...

Researchers have identified a metabolically sensitive cell subtype in the eye's drainage system which shows early signs of ...

Microscopic imaging of trabecular meshwork cells, which play a critical role regulating intraocular pressure. To better understand how the cells function, researchers use fluorescent stains to mark ...

Prostaglandin analogues, such as latanoprost and bimatoprost, are the go-to therapies for glaucoma therapy. They continue to ...

Immunofluorescence staining shows the layers of trabecular meshwork (red) and Schlemm’s canal endothelium (yellow) cells in a 3D “eye-on-a-chip” platform that mimics the flow of ocular fluids. The eye ...

While there’s no cure for glaucoma, treatment can help manage it. Your specialist will create a personalized treatment plan based on your needs. Your treatment may vary depending on certain factors: ...

Please provide your email address to receive an email when new articles are posted on . “It is essential for researchers and industry to continue developing innovative therapeutic options that are ...

California-based medical technology startup ViaLase has announced that its ViaLase Laser device for glaucoma treatment has received CE mark approval. The approval moves the platform towards ...

Glaucoma is a group of eye diseases, most of which are characterized by increased pressure within the eye. This elevated pressure, caused by a backup of fluid, can gradually damage the optic nerve.